|
RPA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.06560024429825E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43940004360132E-09 |
| Normal-vs-Stage2 |
5.506300E-02 |
| Normal-vs-Stage3 |
5.836400E-01 |
| Normal-vs-Stage4 |
1.501780E-01 |
| Stage1-vs-Stage2 |
5.317200E-01 |
| Stage1-vs-Stage3 |
5.52419999999554E-05 |
| Stage1-vs-Stage4 |
3.727000E-01 |
| Stage2-vs-Stage3 |
1.092610E-01 |
| Stage2-vs-Stage4 |
7.554400E-01 |
| Stage3-vs-Stage4 |
1.697780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31870000977352E-09 |
| Normal-vs-AfricanAmerican |
4.23940000000567E-05 |
| Normal-vs-Asian |
2.439600E-01 |
| Caucasian-vs-AfricanAmerican |
6.965600E-01 |
| Caucasian-vs-Asian |
7.460400E-01 |
| AfricanAmerican-vs-Asian |
8.792200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41940031844956E-10 |
| Normal-vs-Female |
7.50310000000587E-05 |
| Male-vs-Female |
6.515500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.561300E-03 |
| Normal-vs-Extreme_Weight |
4.31790000421373E-08 |
| Normal-vs-Obese |
4.07040000000025E-05 |
| Normal-vs-Extreme_Obese |
3.376800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.991600E-02 |
| Normal_Weight-vs-Obese |
2.019600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.527000E-01 |
| Extreme_Weight-vs-Obese |
4.235000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.026800E-01 |
| Obese-vs-Extreme_Obese |
3.834800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.805800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.06739999949923E-07 |
| Normal-vs-Age(61-80Yrs) |
2.23299999602133E-08 |
| Normal-vs-Age(81-100Yrs) |
1.519790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.299800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.683800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.907000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.717200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.436400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.478400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.4432899320127E-15 |
| Normal-VS-Type2 PRCC |
2.404300E-02 |
| Normal-VS-KIRP CIMP |
8.293400E-01 |
| Normal-VS-Unclassified PRCC |
4.805500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.04879999998742E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.780140E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.030300E-04 |
| Type2 PRCC-VS-KIRP CIMP |
2.500600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.294200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.019200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.046500E-04 |
| Normal-vs-N1 |
6.388400E-01 |
| Normal-vs-N2 |
3.340000E-01 |
| N0-vs-N1 |
5.560000E-02 |
| N0-vs-N2 |
9.020400E-01 |
| N1-vs-N2 |
4.376200E-01 |
|
|
